Company

Ningbo Menovo Pharmaceutical Co. Ltd

Headquarters: Ningbo, China

Employees: 2,432

SSE: 603538 +10.01%

Market Cap

CN¥2.74 Billion

CNY as of Jan. 1, 2025

US$375.3 Million

Market Cap History

Ningbo Menovo Pharmaceutical Co. Ltd Categories

China Healthcare Drug Manufacturers—Specialty & Generic
China Healthcare China Drug Manufacturers—Specialty & Generic

Ningbo Menovo Pharmaceutical Co. Ltd market capitalization over time

Evolution of Ningbo Menovo Pharmaceutical Co. Ltd market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Ningbo Menovo Pharmaceutical Co. Ltd

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $75.33 B
MERCK Kommanditgesellschaft auf Aktien $65.17 B
Haleon plc $42.16 B
Takeda Pharmaceutical Company Limited $41.47 B
Teva Pharmaceutical Industries Limited $18.95 B
Sector:
Company Market Cap (USD)
Lilly $689.42 B
Novo Nordisk $622.07 B
UnitedHealth Group $487.54 B
Johnson & Johnson $353.05 B
AbbVie $301.60 B

Detailed Description

Ningbo Menovo Pharmaceutical Co., Ltd. research, develops, produces, and sells pharmaceutical products. It offers APIs, intermediates, and formulations for the treatment of cardiovascular, central nervous, respiratory, antitumor, anti-infection, digestive, and geriatric diseases, as well as antiviral. The company was founded in 2004 and is headquartered in Ningbo, China.

Stocks & Indices

Ningbo Menovo Pharmaceutical Co. Ltd has the following listings and related stock indices.


Stock: SSE: 603538 wb_incandescent

Details

Headquarters:

Building 1

13th Floor Ningbo R&D Park, No. 999, Yangfan Road Hi-Tech District

Ningbo, 315040

China

Phone: 86 574 8791 8616

Fax: 86 574 8791 6081